BNP Paribas Exane Forecasts Strong Price Appreciation for BlackRock (NYSE:BLK) Stock - MarketBeat
π BNP Paribas Exane raised its BlackRock price target to $1,350 from $1,300 with an 'outperform' rating.
π° The company beat quarterly EPS estimates of $12.40 with actual results of $12.53.
π Revenue reached $6.70 billion, representing a 27% year-over-year increase.
π CEO Laurence Fink sold 33,900 shares worth approximately $35.6 million in late April.
π President Robert Kapito sold 8,739 shares valued at roughly $9.2 million during the same period.
π¦ The firm reported a net margin of 24.40% and a return on equity of 14.74% for the quarter.
π Analyst consensus price target stands at $1,267.39 with a 'Moderate Buy' rating overall.
π Institutional ownership remains high at 80.69% of the company's stock.
πΌ Several hedge funds added new positions in Q4, including RMG Wealth and Evolution Wealth.
π BlackRock stock traded down $9.61 to hit $1,042.13 during mid-day trading on Tuesday.
- BNP Paribas Exane raised its price target to $1,350, implying nearly 30% upside from current levels.
- BlackRock beat quarterly EPS expectations of $12.40 with actual earnings of $12.53 per share.
- Revenue surged 27% year over year to reach $6.70 billion, exceeding analyst estimates.
- The company achieved a strong net margin of 24.40% and a return on equity of 14.74%.
- Analyst consensus remains constructive with a 'Moderate Buy' rating and a price target of $1,267.39.
- CEO Laurence Fink sold 33,900 shares worth approximately $35.6 million, reducing his ownership by 12.82%.
- President Robert Kapito sold 8,739 shares valued at roughly $9.2 million, decreasing his stake by 3.99%.
- Stock price dropped $9.61 to $1,042.13 during mid-day trading on Tuesday.